Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20173
20193
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Celgene2
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Hoffmann-La Roche1
I.M. Sechenov First Moscow State Medical University1
Kyntra Bio1
NPO Petrovax1
R-Pharm International, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial11
Idiopathic Pulmonary Fibrosis4
Idiopathic Interstitial Pneumonias3
Fibrosis2
Lung Diseases2
Pulmonary Fibrosis2
Alveolitis, Extrinsic Allergic1
Asthma1
COVID-191
Cardiovascular Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.